Vel Blood Group System: a Review J.R

Total Page:16

File Type:pdf, Size:1020Kb

Vel Blood Group System: a Review J.R Journal of Blood Group Serology and Molecular Genetics VOLUME 33, N UMBER 2, 2017 This issue of Immunohematology is supported by a contribution from Grifols Diagnostics Solutions, Inc. Dedicated to advancement and education in molecular and serologic immunohematology Immunohematology Journal of Blood Group Serology and Molecular Genetics Volume 33, Number 2, 2017 CONTENTS C ASE R EPO R T 51 Hematologic complications in a patient with Glycine soja polyagglutination following fresh frozen plasma transfusion R.P. Jajosky, L.O. Cook, E. Manaloor, J.F. Shikle, and R.J. Bollag R EVIEW 56 The Vel blood group system: a review J.R. Storry and T. Peyrard C ASE R EPO R T 60 Two cases of the variant RHD*DAU5 allele associated with maternal alloanti-D J.A. Duncan, S. Nahiriniak, R. Onell, and G. Clarke R EVIEW 64 The FORS awakens: review of a blood group system reborn A.K. Hult and M.L. Olsson C ASE R EPO R T 73 A suspected delayed hemolytic transfusion reaction mediated by anti-Joa R.P. Jajosky, W.C. Lumm, S.C. Wise, R.J. Bollag, and J.F. Shikle R EVIEW 76 Recognizing and resolving ABO discrepancies G.M. Meny B OOK R EVIEW 82 Bloody Brilliant: A History of Blood Groups and Blood Groupers S. Gerald Sandler 84 90 94 96 A NNOUN C EMENTS A DVE R TISEMENTS I NST R U C TIONS S U B S cr IPTION FO R A UTHO R S I NFO R M AT I O N E DITO R - IN -C HIEF E DITO R IAL B OA R D Sandra Nance, MS, MT(ASCP)SBB Philadelphia, Pennsylvania Patricia Arndt, MT(ASCP)SBB Geralyn M. Meny, MD Pomona, California San Antonio, Texas M ANAGING E DITO R Barbara J. Bryant, MD Paul M. Ness, MD Cynthia Flickinger, MT(ASCP)SBB Galveston, Texas Baltimore, Maryland Wilmington, Delaware Lilian M. Castilho, PhD Thierry Peyrard, PharmD, PhD Campinas, Brazil Paris, France TEC HNI C AL E DITO R S Christine Lomas-Francis, MSc Martha R. Combs, MT(ASCP)SBB S. Gerald Sandler, MD New York City, New York Durham, North Carolina Washington, District of Columbia Joyce Poole, FIBMS Geoffrey Daniels, PhD Ira A. Shulman, MD Bristol, United Kingdom Bristol, United Kingdom Los Angeles, California Dawn M. Rumsey, ART(CSMLT) Anne F. Eder, MD Jill R. Storry, PhD Washington, District of Columbia Lund, Sweden Norcross, Georgia Melissa R. George, DO, FCAP Nicole Thornton S ENIO R M EDI C AL E DITO R Hershey, Pennsylvania Bristol, United Kingdom David Moolten, MD Julie K. Karp, MD Philadelphia, Pennsylvania Philadelphia, Pennsylvania E ME R ITUS E DITO R S Jose Lima, MD Delores Mallory, MT(ASCP)SBB A SSO C I AT E M EDI C AL E DITO R S Douglassville, Georgia Supply, North Carolina P. Dayand Borge, MD Philadelphia, Pennsylvania Christine Lomas-Francis, MSc Marion E. Reid, PhD, FIBMS New York City, New York Bristol, United Kingdom Corinne L. Goldberg, MD Durham, North Carolina M OLEC ULA R E DITO R Margaret A. Keller, PhD Philadelphia, Pennsylvania Immunohematology is published quarterly (March, June, September, and December) by the E DITO R IAL A S S I S TA N T American Red Cross, National Headquarters, Washington, DC 20006. Linda Frazier Immunohematology is indexed and included in Index Medicus and MEDLINE on the MEDLARS system. The contents are also cited in the EBASE/Excerpta Medica and Elsevier P R ODU C TION A S S I S TA N T BIOBASE/Current Awareness in Biological Sciences (CABS) databases. Marge Manigly The subscription price is $50 for individual, $100 for institution (U.S.), and $60 for individual, $100 for institution (foreign), per year. C OPY E DITO R Subscriptions, Change of Address, and Extra Copies: Frederique Courard-Houri Immunohematology, P.O. Box 40325 Philadelphia, PA 19106 P R OOF R EADE R Wendy Martin-Shuma Or call (215) 451-4902 Web site: www.redcrossblood.org/hospitals/immunohematology E LEC T R ONI C P U B LISHE R Copyright 2017 by The American National Red Cross Paul Duquette ISSN 0894-203X O N O U R C OVE R Girl with a Red Hat (1666) by Johannes Vermeer is an example of a tronie, derived from Dutch meaning “face” and referring to a stylized work common to the Dutch Golden Age that, distinct from formal portrait painting, featured an anonymous model with an exaggerated expression or depicted as an iconic character. Girl with a Red Hat employs bold, rich colors, and the girl’s eye-catching hat and robe and informal turn to face the viewer are striking and engaging. Vermeer created only two other panel works, and the painting’s flamboyance and use of wood as a support medium have caused some to question its attribution, though dendrological analysis as well as technique considerations favor Vermeer. One of Vermeer’s more famous works, at just 9 × 71/16 inches, Girl with a Red Hat is also one of his smallest. Small integral membrane protein 1 (SMIM1) is the subject of an article in this issue. David Moolten, MD CASE R EPO R T Hematologic complications in a patient with Glycine soja polyagglutination following fresh frozen plasma transfusion R.P. Jajosky, L.O. Cook, E. Manaloor, J.F. Shikle, and R.J. Bollag Polyagglutination is a rare and underdiagnosed condition, to infection1,2 rather than to a congenital or somatic mutation. characterized by agglutination of red blood cells (RBCs) with T activation is the most common form of microbial-induced almost all ABO-compatible adult sera. Polyagglutination can polyagglutination and serves as a prototypical example occur when a cryptantigen is exposed on RBCs via microbial 3 enzyme activity. Because nearly all adults naturally produce (Fig. 1). Antibodies against cryptantigens are naturally antibodies against cryptantigens, transfusion of plasma can cause occurring and are usually IgM.3 The patient’s own antibodies unexpected hemolysis and hematologic complications, such as may mediate hemolysis.4 However, it is more common for thrombocytopenia and disseminated intravascular coagulation, in patients whose cryptantigens are exposed. We report a case hemolysis to occur after the transfusion of blood components of Glycine soja polyagglutination occurring in a 60-year-old that contain plasma.5–7 Thrombocytopenia may develop African-American man with disseminated methicillin-resistant because of the presence of the cryptantigen on platelets Staphylococcus aureus (MRSA) infection. Prior to transfusion, (PLTs).8,9 In addition, coagulopathies, such as disseminated the patient developed severe anemia of unknown etiology. 5,10 Following transfusion of 3 units of fresh frozen plasma (FFP), his intravascular coagulation (DIC), often occur. RBC count could not be determined for 24 days because of RBC agglutination in his blood sample. In addition, the FFP transfusion correlated with the rapid development of severe, transfusion- Sialidase refractory thrombocytopenia and anemia. The perplexed clinic- al team consulted the blood bank. A direct antiglobulin test demonstrated 1+ mixed-field reactivity with both monoclonal anti-IgG and anti-C3d. Lectin panel testing showed reactivity with only Glycine soja, confirming the condition. Subsequently, plasma components were avoided, and RBC and platelet (PLT) components were washed prior to transfusion. After a 44-day hospitalization involving the transfusion of 22 units of RBCs and 13 units of PLTs, the patient was discharged to a long-term care facility. The patient’s confounding hematologic complications can best be explained by polyagglutination, which developed Healthy RBC Membrane Abnormal RBC Membrane secondary to the severe MRSA infection. The FFP transfusion likely passively transferred antibodies that bound to the patient’s Fig. 1 Microbial enzymes such as sialidases (circle sector shape) RBC cryptantigens, leading to RBC agglutination and anemia. can enzymatically remove N-acetylneuraminic acid (triangles) from The development of severe thrombocytopenia may be related to RBC antigens. This action exposes normally hidden cryptantigens, cryptantigen exposure on the patient’s PLTs. Although difficult to such as T (shown on the right), which can subsequently bind anti-T. identify, polyagglutination needs to be recognized to appropriately This particular type of polyagglutination is known as T activation. manage hemotherapy. The purpose of this case study is to report This form is often described in pediatric patients with necrotizing hematologic complications following FFP transfusion in a patient enterocolitis or atypical hemolytic uremic syndrome caused by with Glycine soja polyagglutination, a rarely described condition. Streptococcus pneumoniae. T is also present on platelets and Immunohematology 2017;33:51–55. glomerular endothelial cells. The circle designates D-galactose. The square designates N-acetyl-D-galactosamine. R = Remainder of molecule; RBC = red blood cell. Key Words: unclassified polyagglutination, Glycine soja, Staphylococcus aureus, lectin, minor crossmatch, T activation In the past, polyagglutination was readily detected by blood Polyagglutination describes the agglutination of red blood centers when ABO typing resulted in ABO discrepancies.8,11 cells (RBCs) that occurs with nearly all compatible adult This finding occurred because human-source sera containing sera.1,2 It arises through an alteration of glycoprotein moieties antibodies against cryptantigens were used for blood typing. on the RBC membrane. This condition is usually secondary The transition to monoclonal antibodies for blood typing IMMUNOHEMATOLOGY, Volume 33, Number 2, 2017 51 R.P. Jajosky et al. eliminated these ABO discrepancies. In addition, most two incision and drainage (I&D) procedures of the septic blood centers do not routinely screen for polyagglutination.12 knee. Subsequently, his hemoglobin declined from 11.4 to Therefore, polyagglutination is becoming under-recognized. 7.1 g/dL (reference range: 14.0–18.0 g/dL) for unknown To identify polyagglutination, the condition must be suspected reasons (Fig. 2). The patient’s blood typed as group A, D+, by either clinicians or blood bank personnel, and additional and multiple RBC units were transfused.
Recommended publications
  • Study of Blood Group (ABO and RH) Association and Secretor Status of ABH Substances in Patients with Systemic Lupus Erythematosus
    IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861.Volume 18, Issue 5 Ser. 12 (May. 2019), PP 31-35 www.iosrjournals.org Study of Blood Group (ABO and RH) Association and Secretor Status of ABH Substances in Patients with Systemic Lupus Erythematosus Dr. Tashi Paleng1, Dr. A. Barindra Sharma2, Dr.Santa Naorem3, Dr. Laikangbam Dayalaxmi4, Dr. Eric Hilton Wanniang5, Dr. Eswara Moorthy G6 1Postgraduate trainee, 2Professor & Head, 3Professor, 4Senoir Resident, 5Postgraduate trainee, 6Postgraduate trainee 1,2,4,5,6Department of Transfusion Medicine, 3Department of Medicine, Regional Institute of Medical Sciences, Imphal-795004, Manipur, India Corresponding Author: Dr. Tashi Paleng Abstract: Individuals who secrete their blood group antigens in the body fluids are called secretors and individuals who do not secrete are called non-secretors. Non-secretors of blood group antigens have been found to be associated with many infectious and autoimmune diseases by many previous studies. The aims of our study were to find out any association between ABO blood group, RhD blood group and secretor status of ABH substances with the patients of Systemic Lupus Erythematosus. This Case Control study was carried out in the Department of Transfusion Medicine in collaboration with the Department of Medicine, Regional Institute of Medical Sciences, Imphal Manipur from September 2016 to August 2018. 75 confirmed SLE patients attending Rheumatology OPD, Department of Medicine and 75 healthy sex matched voluntary blood donors attending blood bank, Department of Tranfusion Medicine have been enrolled in the study. Their blood were typed for ABO and RhD groups using conventional tube technique and saliva were tested for secretor and non-secretor status using heamagglutination inhibition test.
    [Show full text]
  • Genetic Screening for the Vel- Phenotype Circumvents Difficult Serological Screening Due to Variable Vel Expression Levels
    UvA-DARE (Digital Academic Repository) Genetic basis of rare blood group variants Wigman, L. Publication date 2013 Link to publication Citation for published version (APA): Wigman, L. (2013). Genetic basis of rare blood group variants. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:28 Sep 2021 Chapter 6 Genetic screening for the Vel- phenotype circumvents difficult serological screening due to variable Vel expression levels Lonneke Haer-Wigman1 Shabnam Solati1 Aïcha Ait Soussan1 Erik Beckers2 Pim van der Harst3 Marga van Hulst-Sundermeijer4 Peter Ligthart1 Dick van Rhenen5 Hein Schepers3 Tamara Stegmann1 Masja de Haas1 C. Ellen van der Schoot1 1 Sanquin Research, Amsterdam and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands 2 Maastricht University Medical Centre+, Maastricht, The Netherlands 3 University Medical Center Groningen, University of Groningen, Groningen, The Netherlands 4 Sanquin Diagnostic Services, Amsterdam, The Netherlands 5 Sanquin Blood Bank, Rotterdam, Netherlands Manuscript under preparation Chapter 6 Abstract Background: Serological determination of the Vel- phenotype is challenging due to variable Vel expression levels.
    [Show full text]
  • Journal of Blood Group Serology and Molecular Genetics Volume 34, Number 1, 2018 CONTENTS
    Journal of Blood Group Serology and Molecular Genetics VOLUME 34, N UMBER 1, 2018 This issue of Immunohematology is supported by a contribution from Grifols Diagnostics Solutions, Inc. Dedicated to advancement and education in molecular and serologic immunohematology Immunohematology Journal of Blood Group Serology and Molecular Genetics Volume 34, Number 1, 2018 CONTENTS S EROLOGIC M ETHOD R EVIEW 1 Warm autoadsorption using ZZAP F.M. Tsimba-Chitsva, A. Caballero, and B. Svatora R EVIEW 4 Proceedings from the International Society of Blood Transfusion Working Party on Immunohaematology Workshop on the Clinical Significance of Red Blood Cell Alloantibodies, Friday, September 2, 2016, Dubai A brief overview of clinical significance of blood group antibodies M.J. Gandhi, D.M. Strong, B.I. Whitaker, and E. Petrisli C A S E R EPORT 7 Management of pregnancy sensitized with anti-Inb with monocyte monolayer assay and maternal blood donation R. Shree, K.K. Ma, L.S. Er and M. Delaney R EVIEW 11 Proceedings from the International Society of Blood Transfusion Working Party on Immunohaematology Workshop on the Clinical Significance of Red Blood Cell Alloantibodies, Friday, September 2, 2016, Dubai A review of in vitro methods to predict the clinical significance of red blood cell alloantibodies S.J. Nance S EROLOGIC M ETHOD R EVIEW 16 Recovery of autologous sickle cells by hypotonic wash E. Wilson, K. Kezeor, and M. Crosby TO THE E DITOR 19 The devil is in the details: retention of recipient group A type 5 years after a successful allogeneic bone marrow transplant from a group O donor L.L.W.
    [Show full text]
  • In Vitro Selection for Adhesion of Plasmodium Falciparum-Infected Erythrocytes to ABO Antigens Does Not Affect Pfemp1 and RIFIN
    www.nature.com/scientificreports OPEN In vitro selection for adhesion of Plasmodium falciparum‑infected erythrocytes to ABO antigens does not afect PfEMP1 and RIFIN expression William van der Puije1,2, Christian W. Wang 4, Srinidhi Sudharson 2, Casper Hempel 2, Rebecca W. Olsen 4, Nanna Dalgaard 4, Michael F. Ofori 1, Lars Hviid 3,4, Jørgen A. L. Kurtzhals 2,4 & Trine Staalsoe 2,4* Plasmodium falciparum causes the most severe form of malaria in humans. The adhesion of the infected erythrocytes (IEs) to endothelial receptors (sequestration) and to uninfected erythrocytes (rosetting) are considered major elements in the pathogenesis of the disease. Both sequestration and rosetting appear to involve particular members of several IE variant surface antigens (VSAs) as ligands, interacting with multiple vascular host receptors, including the ABO blood group antigens. In this study, we subjected genetically distinct P. falciparum parasites to in vitro selection for increased IE adhesion to ABO antigens in the absence of potentially confounding receptors. The selection resulted in IEs that adhered stronger to pure ABO antigens, to erythrocytes, and to various human cell lines than their unselected counterparts. However, selection did not result in marked qualitative changes in transcript levels of the genes encoding the best-described VSA families, PfEMP1 and RIFIN. Rather, overall transcription of both gene families tended to decline following selection. Furthermore, selection-induced increases in the adhesion to ABO occurred in the absence of marked changes in immune IgG recognition of IE surface antigens, generally assumed to target mainly VSAs. Our study sheds new light on our understanding of the processes and molecules involved in IE sequestration and rosetting.
    [Show full text]
  • Journal of Blood Group Serology and Molecular Genetics Volume 33, Number 3, 2017 CONTENTS
    Journal of Blood Group Serology and Molecular Genetics VOLUME 33, N UMBER 3, 2017 This issue of Immunohematology is supported by a contribution from Grifols Diagnostics Solutions, Inc. Dedicated to advancement and education in molecular and serologic immunohematology Immunohematology Journal of Blood Group Serology and Molecular Genetics Volume 33, Number 3, 2017 CONTENTS C ASE R EPO R T 99 ABO serology in a case of persistent weak A in a recipient following a group O–matched unrelated bone marrow transplant D.E. Grey, E.A. Fong, C. Cole, J. Jensen, and J. Finlayson O R IGINAL R EPO R T 105 Stability guidelines for dithiothreitol-treated red blood cell reagents used for antibody detection methods in patients treated with daratumumab W.L. Disbro C ASE R EPO R T 110 A LU:−16 individual with antibodies C. Éthier, C. Parent, A.-S. Lemay, N. Baillargeon, G. Laflamme, J. Lavoie, J. Perreault, and M. St-Louis C ASE R EPO R T 114 Postpartum acute hemolytic transfusion reactions associated with anti-Lea in two pregnancies complicated by preeclampsia M. Marchese O R IGINAL R EPO R T 119 Red blood cell phenotype prevalence in blood donors who self- identify as Hispanic C.A. Sheppard, N.L. Bolen, B. Eades, G. Ochoa-Garay, and M.H. Yazer R EVIEW 125 DEL Phenotype D.H. Kwon, S.G. Sandler, and W.A. Flegel 133 138 142 144 A NNOUN C EMENTS A DVE R TISEMENTS I NST R U C TIONS S UBS cr IPTION FO R A UTHO R S I NFO R M AT I O N E DITO R - IN -C HIEF E DITO R IAL B OA R D Sandra Nance, MS, MT(ASCP)SBB Philadelphia, Pennsylvania Patricia Arndt, MT(ASCP)SBB Geralyn M.
    [Show full text]
  • Blood Group Genomics
    BLOOD GROUP GENOMICS Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis of 36 blood group alleles among 396 Thai samples reveals region-specific variants Philaiphon Jongruamklang,1 Christoph Gassner,2 Stefan Meyer,2 Aksarakorn Kummasook,3 Marion Darlison,1 Chayanun Boonlum,4 Surin Chanta,5 Beat M. Frey,2 Martin L. Olsson,1,6* and Jill R. Storry 1,6* lood group antigen polymorphism shows great BACKGROUND: Blood group phenotype variation has variation in different world populations. The been attributed to potential resistance to pathogen reason for this is not completely understood; invasion. Variation was mapped in blood donors from however, it has been attributed to both Lampang (northern region) and Saraburi (central region), B Thailand, where malaria is endemic. The previously unknown blood group allele profiles were characterized ABBREVIATIONS: MALDI-TOF MS 5 matrix-assisted laser and the data were correlated with phenotypes. The high desorption/ionization time-of-flight mass spectrometry; PCR- incidence of the Vel-negative phenotype previously ASP 5 polymerase chain reaction with allele-specific reported in Thais was investigated. primers; SNP(s) 5 single nucleotide polymorphism(s). STUDY DESIGN AND METHODS: DNA from 396 From 1Hematology and Transfusion Medicine, Department of blood donors was analyzed by matrix-assisted laser Laboratory Medicine, Lund University, Lund, Sweden; desorption/ionization–time-of-flight mass spectrometry. 2Molecular Diagnostics & Research (MOC), Blood Transfusion Outliers were investigated by serology and DNA Service Zurich,€ Zurich-Schlieren,€ Switzerland; 3Department of sequencing. Allele discrimination assays for SMIM1 Medical Technology, School of Allied Health Sciences, rs1175550A/G and ACKR1 rs118062001C/T were University of Phayao, Phayao, Thailand; 4Transfusion Medicine, performed and correlated with antigen expression.
    [Show full text]
  • Transfusion Medicine
    Transfusion Medicine Dr. Raymond SM Wong Department of Medicine & Therapeutics Prince of Wales Hospital The Chinese University of Hong Kong Content Blood groups Cross-matching and pre-transfusion tests Blood components and blood products Complications of blood transfusion Blood transfusion in specific situations Blood groups ( 血型) Determined by the red cell antigens ( 紅血球抗原) About 400 red blood cell group antigens have been described Individual who lack a particular blood group antigen may produce antibodies ( 抗體) reacting with that antigen and may lead to a transfusion reaction ( 輸血 反應) ABO and rhesus ( 獼因子) groups are the most clinically significant blood groups Blood group antibodies Naturally occurring antibodies occur in plasma of subjects who lack the corresponding antigen and who have not been transfused or been pregnant Most important are anti-A and anti-B Immune antibodies Develop in response to exposure to antigens by transfusion or by trans-placental passage during pregnancy Most important is the Rhesus (Rh) antibody, anti-D ABO blood group system Consists of 3 allelic genes: A, B and O A and B gene control the synthesis of specific enzymes which transform the H substance Ceramide glu gal gnac gal fuc H antigen galnac Ceramide glu gal gnac gal A antigen fuc gal Ceramide glu gal gnac gal B antigen fuc Cell membrane ABO blood group system Phenotype Genotype Naturally occurring (表型) (基因型) Antigens antibodies O OO O Anti-A, anti-B A AA or AO A Anti-B B BB or BO B Anti-A AB AB AB None The O gene is an amorph (無效基因)
    [Show full text]
  • Transfusion in a Rare Case of Para-Bombay Phenotype
    TRANSFUSION IN A RARE CASE OF PARA-BOMBAY PHENOTYPE Charlotte Engström1, Stefan Meyer2, Young-Lan Song1, Adriana Komarek1, Alix O’Meara3, Claudia Papet3, Kathrin Neuenschwander2, Christoph Gassner2, Beat M. Frey1 1 Immunohematology, Blood Transfusion Service Zurich, Swiss Red Cross, Switzerland. 2 Molecular Diagnostics & Research, Blood Transfusion Service Zurich, Swiss Red Cross , Switzerland. 3 Hematology/Oncology, Spital Limmattal, Schlieren, Switzerland. Background Results Individuals with Bombay phenotype are characterized by the The routine anti-A, -B and -A/B failed to detect the respective absence of ABH blood group antigens both on the surface of antigens and, most notably, no H-antigen was traceable. The red blood cells (RBCs) and in secretions resulting from RBCs showed only weak agglutination with the potent anti-A/B silenced mutations in FUT1 (h/h) and FUT2 (se/se) genes, serum (Grifols). Only anti-H, but no anti-A or anti-B, was respectively. In contrast, para-Bombay phenotype retains identified in the serum. Initial ABO genotyping by sequence- some H antigen on RBCs either induced from a weakly active specific priming (PCR-SSP) resulted in AB genotype. In order (H+weak/H+weak) or completely silenced FUT1 gene (h/h). to confirm serological H-deficient phenotype a more detailed The latter is mandatory linked with an active FUT2 gene analysis was performed including sequencing of FUT1 and (Se/Se or Se/se) enabling synthesis of ABH-antigens in FUT2 which revealed an active secretor status (Se/Se) but secretions which may be adsorbed from the plasma onto homozygosity for the FUT1*01W.09 allele (c.658C>T, RBCs surface (1, 2).
    [Show full text]
  • The Incidence of Spontaneous Abortion in Mothers with Blood Group O Compared with Other Blood Types
    IJMCM Meta analysis Spring 2012, Vol 1, No 2 The incidence of spontaneous abortion in mothers with blood group O compared with other blood types ∗ Mohammad Hassanzadeh-Nazarabadi 1∗∗, Sahar Shekouhi 1, Najmeh Seif 1 Faculty of Medicince, Department of Medical Genetics, Mashhad University of Medical Sciences, Mashhad, Iran Although ABO incompatibility between mother and fetus has long been suspected as cause of spontaneous abortion in man, its precise contribution has not been completely resolved. In spite of reports in which the incompatible mating was recognized to be a cause of habitual abortion, and which eventually results in infertility or a reduction in the number of living children compared with the number in compatible matings, such effects were not observed in other studies. The aim of this review article was to show some evidence of relationship between ABO incompatibility and spontaneous abortion. Key words: spontaneous abortion, ABO blood group, incompatibility In 1900 Karl Landsteiner reported a series of discovered, attention was directed toward the tests, which identified the ABO blood group system. possibility of harmful effects when mother and This is the only blood group in which antibodies are fetus have different blood groups. As early as 1905 constantly, predictably, and naturally present in the A. Dienst suggested that toxemia of pregnancy serum of people who lack the antigen. ABO might be due to the transfusion of ABO- compatibility between mother and fetus is crucial (1). incompatible fetal blood into the mother. This was not substantiated, and the problem of ABO Downloaded from ijmcmed.org at 17:08 +0330 on Saturday September 25th 2021 Abortion interaction between mother and fetus was largely Spontaneous abortion also known as overshadowed by the more dramatic effects of Rh miscarriage, refers to a pregnancy that ends incompatibility leading to Rh hemolytic disease.
    [Show full text]
  • Glycophorins and the MNS Blood Group System: a Narrative Review
    16 Review Article Page 1 of 16 Glycophorins and the MNS blood group system: a narrative review Genghis H. Lopez1,2, Catherine A. Hyland1,3, Robert L. Flower1,3 1Clinical Services and Research Division, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia; 2School of Medical Science, Griffith Health, Griffith University, Gold Coast, Queensland, Australia; 3School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia Contributions: (I) Conception and design: All authors; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Genghis H. Lopez, PhD. Clinical Services and Research Division, Australian Red Cross Lifeblood, 44 Musk Avenue, Kelvin Grove, Queensland 4059, Australia. Email: [email protected]. Abstract: The MNS blood group system, International Society of Blood Transfusion (ISBT) 002, is second after the ABO system. GYPA and GYPB genes encode MNS blood group antigens carried on glycophorin A (GPA), glycophorin B (GPB), or on variant glycophorins. A third gene, GYPE, produce glycophorin E (GPE) but is not expressed. MNS antigens arise from several genetic mechanisms. Single nucleotide variants (SNVs) contribute to the diversity of the MNS system. A new antigen SUMI (MNS50), p.Thr31Pro on GPA has been described in the Japanese population. Unequal crossing-over and gene conversion are the mechanisms forming hybrid glycophorins, usually from parent genes GYPA and GYPB. GYPE also contributes to gene recombination previously only described with GYPA. Recently, however, GYPE was shown to recombine with GYPB to form a GYP(B-E-B) hybrid.
    [Show full text]
  • Comprehensive Red Blood Cell and Platelet Antigen Prediction from Whole Genome Sequencing: Proof of Principle
    BLOOD GROUP GENOMICS Comprehensive red blood cell and platelet antigen prediction from whole genome sequencing: proof of principle William J. Lane,1,2 Connie M. Westhoff,3 Jon Michael Uy,1 Maria Aguad,1 Robin Smeland-Wagman,1 Richard M. Kaufman,1 Heidi L. Rehm,1,2,4,5 Robert C. Green,2,5,6 and Leslie E. Silberstein7 for the MedSeq Project* rediction of red blood cell (RBC) and platelet BACKGROUND: There are 346 serologically defined (PLT) antigens using DNA assays has the poten- red blood cell (RBC) antigens and 33 serologically tial to augment or replace traditional serologic defined platelet (PLT) antigens, most of which have antigen typing in many situations. DNA-based known genetic changes in 45 RBC or six PLT genes that P typing methods are more easily automated, amenable to correlate with antigen expression. Polymorphic sites multiplexing, and do not require expensive and some- associated with antigen expression in the primary times difficult to obtain serologic immunoglobulin literature and reference databases are annotated according to nucleotide positions in cDNA. This makes antigen prediction from next-generation sequencing data ABBREVIATIONS: CDS 5 coding DNA sequence; NGS 5 challenging, since it uses genomic coordinates. next-generation sequencing; SNP(s) 5 single-nucleotide STUDY DESIGN AND METHODS: The conventional polymorphism(s); WGS 5 whole genome sequencing. cDNA reference sequences for all known RBC and PLT From the 1Department of Pathology, the 6Division of Genetics, genes that correlate with antigen expression were Department of Medicine, and the 7Division of Transfusion aligned to the human reference genome. The alignments Medicine, Department of Pathology, Brigham and Women’s allowed conversion of conventional cDNA nucleotide Hospital; and 2Harvard Medical School, Boston, Massachusetts; positions to the corresponding genomic coordinates.
    [Show full text]
  • Clinical Significance of Antibodies to Antigens in the Raph, John Milton
    R EVIEW Proceedings from the International Society of Blood Transfusion Working Party on Immunohaematology, Workshop on the Clinical Significance of Red Blood Cell Alloantibodies, September 2, 2016, Dubai Clinical significance of antibodies to antigens in the Raph, John Milton Hagen, I, Globoside, Gill, Rh-associated glycoprotein, FORS, JR, LAN, Vel, CD59, and Augustine blood group systems M. Moghaddam and A.A. Naghi This article reviews information on the clinical significance and 6 shared missense mutation c.511C>T (p.Argl71Cys) as of antibodies to antigens in the Raph, John Milton Hagen, I, well as a synonymous single-nucleotide mutation (c.579A>G) Globoside, Gill, Rh-associated glycoprotein, FORS, JR, LAN, Vel, and had no clinical features. Although the CD151 protein is CD59, and Augustine blood group systems. Antibodies to many of the antigens in these groups are rarely encountered because of the critical to cell adhesion and signaling and is implicated in high prevalence of the associated antigens in most populations. cancer progression, its significance in transfusion medicine is For many of these antibodies, the clinical significance—that is, limited to only one report of a hemolytic transfusion reaction the potential to cause reduced survival of transfused antigen- 3 positive red blood cells or a transfusion reaction (e.g., anti-P, (HTR). Least-incompatible RBC units should be selected anti-Jra, and anti-Lan), and/or hemolytic disease of the fetus and for transfusion to patients with anti-MER2.2 No information newborn (e.g., anti-RHAG4 and anti-Vel)—has been documented. on anti-MER2 causing hemolytic disease of the fetus and For other antibodies, their prevalence is so rare that information newborn (HDFN) is available.4 on the clinical significance of their antibodies is not available (e.g., anti-FORS1).
    [Show full text]